Effect of Levonorgestrel Intrauterine System on Hemoglobin Level

Effect of Levonorgestrel Intrautrine System on Hemoglobin Level and Iron Profile on Women Requiring Contraception

To study the effect of LNG-IUS on improving iron status in reproductive-aged women presenting for contraception.

Women come to family planning clinic to insert levonorgestrel intrautrine system and take a blood sample from her to analyse hemoglobin level

Inclusion Criteria:

1. The study will include married women attending the outpatient clinics of the forementioned health facilities for contraception counseling
2. Age between 18 and 45 years
3. Women who choose LNG_IUS for contraception
4. Any parity including nulliparous

Exclusion Criteria:

• 1.Women with any inherited hemoglobinopathy (thalassemia, sickle cell anemia) or acquired hemolytic anemia 2.Women with sever iron deficiency anemia requiring immediate treatment 3.Women with any contraindication to Mirena insertion (pelvic inflammatory disease, cervical or vaginal infection, cervical cancer) 4. Any uterine abnormality making LNG_IUS insertion difficult (septate uterus or fibroid distorting the cavity) 5. Women within 6 months of delivery